Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 10;61(41):e202209499.
doi: 10.1002/anie.202209499. Epub 2022 Sep 1.

Physical and Chemical Cues at the Nano-Bio Interface for Immunomodulation

Feng-Yuan Wang  1 , Tianze Qiu  1 , Yun Ling  1 , Yannan Yang  2 , Yaming Zhou  1
Affiliations
Review

Physical and Chemical Cues at the Nano-Bio Interface for Immunomodulation

Feng-Yuan Wang et al. Angew Chem Int Ed Engl. .

Abstract

Immunomodulation has made remarkable progress in fighting infectious disease and cancer. Conventionally, immunomodulation largely relies on chemical/biochemical agents, which, unfortunately, suffer from sever off-target adverse effects. Recent insights into nano-bio interactions suggest that nanomaterials can directly participate in immunomodulation. A range of physical and chemical cues at the nano-bio interface have been harnessed to regulate diverse immuno-signaling for disease control and treatment. In this Minireview, we summarize recent studies on the physical and chemical cues enabled by intrinsic nanomaterials to trigger immunological signaling. First, we discuss physical cues mediated by surface topography, hydrophobicity, charge, and heat at the nano-bio interface for immunomodulation. Then, various nanomaterials enabled chemical cues, such as metal species and oxidative species are outlined. Finally, our perspectives on challenges and possible future directions are provided.

Keywords: Antitumor Agents; Immunomodulation; Inflammatory Response; Interfaces; Nano-Bio Interfaces.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. L. Milling, Y. Zhang, D. J. Irvine, Adv. Drug Delivery Rev. 2017, 114, 79-101.
    1. E. Vivier, B. Malissen, Nat. Immunol. 2005, 6, 17-21.
    1. I. J. Amanna, M. K. Slifka in Vaccination Strategies Against Highly Variable Pathogens (Eds.: L. Hangartner, D. R. Burton), Springer International Publishing, Cham, 2020, pp. 1-30.
    1. D. N. Khalil, E. L. Smith, R. J. Brentjens, J. D. Wolchok, Nat. Rev. Clin. Oncol. 2016, 13, 273-290.
    1. A. E. Nel, L. Madler, D. Velegol, T. Xia, E. M. V. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, M. Thompson, Nat. Mater. 2009, 8, 543-557.

Publication types

LinkOut - more resources